miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1567-1576

  Smith, Kristen M ^a   Guerau de Arellano, Mireia ^a   Costinean, Stefan ^a   Williams, Jessica L ^a   Bottoni, Arianna ^a   Cox, Gina Mavrikis ^a   Satoskar, Abhay R ^a   Croce, Carlo M ^a   Racke, Michael K ^a   Lovett Racke, Amy E ^a   Whitacre, Caroline C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; GAMMA INTERFERON; MICRORNA; MICRORNA 29; MICRORNA 29AB1; MICRORNA 29B; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MEMORY T LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEEDBACK, PHYSIOLOGICAL; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MULTIPLE SCLEROSIS; TH1 CELLS;

EID: 84864812650     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103171     Document Type: Article

References (54)

1. Murphy, K. M., and S. L. Reiner. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2: 933-944. (Pubitemid 37323214)
2. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 28: 445-489.
3. Olsson, T., W. W. Zhi, B. Höjeberg, V. Kostulas, Y. P. Jiang, G. Anderson, H. P. Ekre, and H. Link. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J. Clin. Invest. 86: 981-985. (Pubitemid 20327391)
4. Voskuhl, R. R., R. Martin, C. Bergman, M. Dalal, N. H. Ruddle, and H. F. McFarland. 1993. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15: 137-143. (Pubitemid 23276008)
5. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508. (Pubitemid 34546753)
6. Chitnis, T. 2007. The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 79: 43-72.
7. Drulovic, J., E. Savic, T. Pekmezovic, S. Mesaros, N. Stojsavljevic, I. Dujmovic-Basuroski, J. Kostic, V. Vasic, M. Mostarica Stojkovic, and D. Popadic. 2009. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferonbeta treatment? J. Neuroimmunol. 215: 90-95.
8. Schrempf, W., and T. Ziemssen. 2007. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun. Rev. 6: 469-475. (Pubitemid 47069973)
9. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
10. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608. (Pubitemid 29418951)
11. Marine, J. C., D. J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura, and J. N. Ihle. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98: 609-616. (Pubitemid 29418952)
12. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
13. Taganov, K. D., M. P. Boldin, and D. Baltimore. 2007. MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137. (Pubitemid 46329443)
14. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
15. Ambros, V. 2004. The functions of animal microRNAs. Nature 431: 350-355. (Pubitemid 39265675)
16. Selbach, M., B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
17. Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269. (Pubitemid 41043822)
18. Chong, M. M., J. P. Rasmussen, A. Y. Rudensky, and D. R. Littman. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205: 2005-2017.
19. Cobb, B. S., A. Hertweck, J. Smith, E. O'Connor, D. Graf, T. Cook, S. T. Smale, S. Sakaguchi, F. J. Livesey, A. G. Fisher, and M. Merkenschlager. 2006. A role for Dicer in immune regulation. J. Exp. Med. 203: 2519-2527. (Pubitemid 44664621)
20. Liston, A., L. F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004.
21. Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991.
22. Steiner, D. F., M. F. Thomas, J. K. Hu, Z. Yang, J. E. Babiarz, C. D. Allen, M. Matloubian, R. Blelloch, and K. M. Ansel. 2011. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity 35: 169-181.
23. Ma, F., S. Xu, X. Liu, Q. Zhang, X. Xu, M. Liu, M. Hua, N. Li, H. Yao, and X. Cao. 2011. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 12: 861-869.
24. Geiss, G. K., R. E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D. L. Dunaway, H. P. Fell, S. Ferree, R. D. George, T. Grogan, et al. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26: 317-325. (Pubitemid 351355126)
25. Lovett-Racke, A. E., A. E. Rocchini, J. Choy, S. C. Northrop, R. Z. Hussain, R. B. Ratts, D. Sikder, and M. K. Racke. 2004. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21: 719-731. (Pubitemid 39487893)
26. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486. (Pubitemid 44267285)
27. Papadopoulou, A. S., J. Dooley, M. A. Linterman, W. Pierson, O. Ucar, B. Kyewski, S. Zuklys, G. A. Hollander, P. Matthys, D. H. Gray, et al. 2011. The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor. Nat. Immunol. 13: 181-187.
28. Chang, T. C., D. Yu, Y. S. Lee, E. A. Wentzel, D. E. Arking, K. M. West, C. V. Dang, A. Thomas-Tikhonenko, and J. T. Mendell. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40: 43-50.
29. Lovett-Racke, A. E., J. L. Trotter, J. Lauber, P. J. Perrin, C. H. June, and M. K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J. Clin. Invest. 101: 725-730. (Pubitemid 28096067)
30. Mott, J. L., S. Kobayashi, S. F. Bronk, and G. J. Gores. 2007. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140. (Pubitemid 47414372)
31. Garzon, R., C. E. Heaphy, V. Havelange, M. Fabbri, S. Volinia, T. Tsao, N. Zanesi, S. M. Kornblau, G. Marcucci, G. A. Calin, et al. 2009. MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341.
32. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161. (Pubitemid 46507589)
33. Sun, G., H. Li, and J. J. Rossi. 2010. Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3'UTR. Nucleic Acids Res. 38: 239-252.
34. Jing, Q., S. Huang, S. Guth, T. Zarubin, A. Motoyama, J. Chen, F. Di Padova, S. C. Lin, H. Gram, and J. Han. 2005. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623-634. (Pubitemid 40343075)
35. Ma, F., X. Liu, D. Li, P. Wang, N. Li, L. Lu, and X. Cao. 2010. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 184: 6053-6059.
36. Morita, Y., T. Naka, Y. Kawazoe, M. Fujimoto, M. Narazaki, R. Nakagawa, H. Fukuyama, S. Nagata, and T. Kishimoto. 2000. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alphainduced cell death in fibroblasts. Proc. Natl. Acad. Sci. USA 97: 5405-5410. (Pubitemid 30313731)
37. Kai, Z. S., and A. E. Pasquinelli. 2010. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat. Struct. Mol. Biol. 17: 5-10.
38. Schulz, E. G., L. Mariani, A. Radbruch, and T. Höfer. 2009. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 30: 673-683.
39. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142. (Pubitemid 34013982)
40. Junker, A., M. Krumbholz, S. Eisele, H. Mohan, F. Augstein, R. Bittner, H. Lassmann, H. Wekerle, R. Hohlfeld, and E. Meinl. 2009. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132: 3342-3352.
41. Guerau-de-Arellano, M., A. E. Lovett-Racke, and M. K. Racke. 2010. miRNAs in multiple sclerosis: regulating the regulators. J. Neuroimmunol. 229: 3-4.
42. Cox, M. B., M. J. Cairns, K. S. Gandhi, A. P. Carroll, S. Moscovis, G. J. Stewart, S. Broadley, R. J. Scott, D. R. Booth, and J. Lechner-Scott; ANZgene Multiple Sclerosis Genetics Consortium. 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE 5: e12132.
43. De Santis, G., M. Ferracin, A. Biondani, L. Caniatti, M. Rosaria Tola, M. Castellazzi, B. Zagatti, L. Battistini, G. Borsellino, E. Fainardi, et al. 2010. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 226: 165-171.
44. Lindberg, R. L., F. Hoffmann, M. Mehling, J. Kuhle, and L. Kappos. 2010. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 40: 888-898.
45. Giegerich, G., M. Pette, E. Meinl, J. T. Epplen, H. Wekerle, and A. Hinkanen. 1992. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein/major histocompatibility complexes. Eur. J. Immunol. 22: 1331.
46. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718-721.
47. Balashov, K. E., D. R. Smith, S. J. Khoury, D. A. Hafler, and H. L. Weiner. 1997. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94: 599-603. (Pubitemid 27053679)
48. Hellings, N., M. Barée, C. Verhoeven, M. B. D'hooghe, R. Medaer, C. C. Bernard, J. Raus, and P. Stinissen. 2001. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J. Neurosci. Res. 63: 290-302. (Pubitemid 32115291)
49. Oliver-Martos, B., T. Órpez, M. J. Pinto-Medel, C. Mayorga, J. A. García-León, R. Maldonado-Sanchez, M. Suardíaz, M. Guerrero, G. Luque, L. Leyva, and O. Fernández. 2011. Gene expression in IFNß signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients. J. Neuroimmunol. 230: 153-159.
50. Nunez-Iglesias, J., C. C. Liu, T. E. Morgan, C. E. Finch, and X. J. Zhou. 2010. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5: e8898.
51. Mayr, C., and D. P. Bartel. 2009. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
52. Sandberg, R., J. R. Neilson, A. Sarma, P. A. Sharp, and C. B. Burge. 2008. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320: 1643-1647. (Pubitemid 351931255)
53. Ceolotto, G., I. Papparella, A. Bortoluzzi, G. Strapazzon, F. Ragazzo, P. Bratti, A. S. Fabricio, E. Squarcina, M. Gion, P. Palatini, and A. Semplicini. 2011. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am. J. Hypertens. 24: 241-246.
54. Nicoloso, M. S., H. Sun, R. Spizzo, H. Kim, P. Wickramasinghe, M. Shimizu, S. E. Wojcik, J. Ferdin, T. Kunej, L. Xiao, et al. 2010. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 70: 2789-2798.